Literature DB >> 8643502

Using ubiquitin to follow the metabolic fate of a protein.

F Lévy1, N Johnsson, T Rümenapf, A Varshavsky.   

Abstract

We describe a method that can be used to produce equimolar amounts of two or more specific proteins in a cell. In this approach, termed the ubiquitin/protein/reference (UPR) technique, a reference protein and a protein of interest are synthesized as a polyprotein separated by a ubiquitin moiety. This tripartite fusion is cleaved, cotranslationally or nearly so, by ubiquitin-specific processing proteases after the last residue of ubiquitin, producing equimolar amounts of the protein of interest and the reference protein bearing a C-terminal ubiquitin moiety. In applications such as pulse-chase analysis, the UPR technique can compensate for the scatter of immunoprecipitation yields, sample volumes, and other sources of sample-to-sample variation. In particular, this method allows a direct comparison of proteins' metabolic stabilities from the pulse data alone. We used UPR to examine the N-end rule (a relation between the in vivo half-life of a protein and the identity of its N-terminal residue) in L cells, a mouse cell line. The increased accuracy afforded by the UPR technique underscores insufficiency of the current "half-life" terminology, because in vivo degradation of many proteins deviates from first-order kinetics. We consider this problem and discuss other applications of UPR.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8643502      PMCID: PMC39378          DOI: 10.1073/pnas.93.10.4907

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

Review 1.  The N-end rule.

Authors:  A Varshavsky
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1995

2.  The tails of ubiquitin precursors are ribosomal proteins whose fusion to ubiquitin facilitates ribosome biogenesis.

Authors:  D Finley; B Bartel; A Varshavsky
Journal:  Nature       Date:  1989-03-30       Impact factor: 49.962

Review 3.  Cotranslational processing and protein turnover in eukaryotic cells.

Authors:  S M Arfin; R A Bradshaw
Journal:  Biochemistry       Date:  1988-10-18       Impact factor: 3.162

4.  In vivo degradation of a transcriptional regulator: the yeast alpha 2 repressor.

Authors:  M Hochstrasser; A Varshavsky
Journal:  Cell       Date:  1990-05-18       Impact factor: 41.582

Review 5.  Selective protein degradation: a journey's end within the proteasome.

Authors:  S Jentsch; S Schlenker
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

6.  Universality and structure of the N-end rule.

Authors:  D K Gonda; A Bachmair; I Wünning; J W Tobias; W S Lane; A Varshavsky
Journal:  J Biol Chem       Date:  1989-10-05       Impact factor: 5.157

7.  In vivo half-life of a protein is a function of its amino-terminal residue.

Authors:  A Bachmair; D Finley; A Varshavsky
Journal:  Science       Date:  1986-10-10       Impact factor: 47.728

8.  The degradation signal in a short-lived protein.

Authors:  A Bachmair; A Varshavsky
Journal:  Cell       Date:  1989-03-24       Impact factor: 41.582

9.  Inhibition of the N-end rule pathway in living cells.

Authors:  R T Baker; A Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

10.  A recognition component of the ubiquitin system is required for peptide transport in Saccharomyces cerevisiae.

Authors:  K Alagramam; F Naider; J M Becker
Journal:  Mol Microbiol       Date:  1995-01       Impact factor: 3.501

View more
  31 in total

1.  Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells.

Authors:  Nicolas Blanchard; Takayuki Kanaseki; Hernando Escobar; Frédéric Delebecque; Niranjana A Nagarajan; Eduardo Reyes-Vargas; David K Crockett; David H Raulet; Julio C Delgado; Nilabh Shastri
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

2.  FAT10, a ubiquitin-independent signal for proteasomal degradation.

Authors:  Mark Steffen Hipp; Birte Kalveram; Shahri Raasi; Marcus Groettrup; Gunter Schmidtke
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

3.  Discovery of cellular regulation by protein degradation.

Authors:  Alexander Varshavsky
Journal:  J Biol Chem       Date:  2008-08-15       Impact factor: 5.157

4.  PINK1 is degraded through the N-end rule pathway.

Authors:  Koji Yamano; Richard J Youle
Journal:  Autophagy       Date:  2013-04-17       Impact factor: 16.016

5.  Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum.

Authors:  Nicolas Blanchard; Federico Gonzalez; Marie Schaeffer; Nathalie T Joncker; Tiffany Cheng; Anjali J Shastri; Ellen A Robey; Nilabh Shastri
Journal:  Nat Immunol       Date:  2008-06-29       Impact factor: 25.606

Review 6.  The N-end rule pathway and regulation by proteolysis.

Authors:  Alexander Varshavsky
Journal:  Protein Sci       Date:  2011-08       Impact factor: 6.725

Review 7.  The N-end rule: functions, mysteries, uses.

Authors:  A Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

8.  Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen.

Authors:  M Guéguen; E O Long
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

9.  Substrate-binding sites of UBR1, the ubiquitin ligase of the N-end rule pathway.

Authors:  Zanxian Xia; Ailsa Webster; Fangyong Du; Konstantin Piatkov; Michel Ghislain; Alexander Varshavsky
Journal:  J Biol Chem       Date:  2008-06-19       Impact factor: 5.157

10.  PRT1 of Arabidopsis is a ubiquitin protein ligase of the plant N-end rule pathway with specificity for aromatic amino-terminal residues.

Authors:  Susanne Stary; Xiao-jun Yin; Thomas Potuschak; Peter Schlögelhofer; Victoria Nizhynska; Andreas Bachmair
Journal:  Plant Physiol       Date:  2003-10-09       Impact factor: 8.340

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.